Back to top
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Albemarle Corporation (ALB) - $25 value - yours FREE >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle Corporation (ALB) - $25 value - yours FREE >>
Image: Bigstock
Albemarle to Acquire Lithium Salts Production Assets
Albemarle Corporation (ALB - Free Report) said that it has inked a deal to buy the lithium hydroxide and lithium carbonate conversion assets and supporting business functions currently operated by Jiangxi Jiangli New Materials Science and Technology Co. Ltd.
The transaction, which is subject regulatory clearances and other customary closing conditions, is expected to close by the end of the first quarter of 2017.
The deal includes manufacturing assets located in both Jiangxi and Sichuan, in China, where these assets are aimed at the production of battery-grade lithium carbonate and lithium hydroxide. Jiangli New Materials currently tolls lithium hydroxide and lithium carbonate for Albemarle, using spodumene from Albemarle's Talison joint venture in Australia.
Collectively, the Jiangli New Material assets have an aggregate lithium salts capacity of 15,000 MT/year, with the ability to increase capacity as required to support Albemarle's growth strategy.
The deal will enable Albermarle to strengthen its position in the lithium industry, and enhance its ability to meet its strategic goal of capturing half of the growth in the lithium industry. This transaction will enable the company to supply premium lithium salts to an increased global customer base. On the other hand, with the deal, Jiangli can create additional value for the lithium industry in Asia Pacific and abroad.
ALBEMARLE CORP Price
ALBEMARLE CORP Price | ALBEMARLE CORP Quote
Albemarle is a global specialty chemicals company with its holding leading positions in lithium, bromine, refining catalysts and applied surface treatments.
Albemarle currently holds a Zacks Rank #5 (Strong Sell).
Better-ranked companies in the chemical space include Innospec Inc. (IOSP - Free Report) , The Chemours Company (CC - Free Report) and Innophos Holdings Inc . All of them hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>